Sign up to our newsletter
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
LATEST ALERTS
View all Blogs
Off the hook – research reveals youth health benefits of legalising cannabis
Written by Aidan Semmens | 31st May 2022
What action in the name of sustainability is the CBD industry likely to see?
Written by Freddie Dawson | 19th May 2022
How likely is it that the US will see further delta-8 THC enforcement?
Written by Freddie Dawson | 12th May 2022
UK FSA updates novel food list – but what difference will it make to the market?
Written by Freddie Dawson | 5th May 2022
The common sense of CBD science, and why it doesn’t always come to the fore
Written by Barnaby Page | 21st April 2022
Polish court decision on hemp as novel food could have big ramifications
Written by Freddie Dawson | 14th April 2022
Will Canadian government’s proposal put renewed fizz in cannabinoid drinks?
Written by Lorraine Mullaney | 6th April 2022
Are there lessons for cannabinoids from the new synthetic-nicotine regulation?
Written by Freddie Dawson | 24th March 2022
Another sign of mainstream acceptance as Amazon gets on board with CBD in US
Written by Freddie Dawson | 21st March 2022
Is investing in cannabis in 2022 a smart bet or a ‘dead-money scenario’?
Written by Lorraine Mullaney | 9th March 2022
NORML releases delta-8 THC info that’s both misleading and potentially divisive
Written by Freddie Dawson | 3rd March 2022
The changing face of endorsements as they get more mainstream – and whiter
Written by CannIntelligence | 17th February 2022
Only in California: the fresh vape that’s cannabis and nothing but the cannabis
Written by Aidan Semmens | 9th February 2022
Will UK FSA at last publish an updated list of validated novel food applications?
Written by Freddie Dawson | 2nd February 2022
Despite industry investment, the future remains cloudy for cannabinoid drinks
Written by Lorraine Mullaney | 20th January 2022
How US Democrats’ cannabis reform plans ran aground despite promises
Written by Lorraine Mullaney | 12th January 2022
Colombian insurance policy shows real intent to lead on cannabinoids
Written by Freddie Dawson | 6th January 2022
Legal eagle Kight explains how the USPS could have modified PACT Act regulation
Written by CannIntelligence | 22nd December 2021
Florida bill will not distinguish delta-8 THC from other hemp-derived products
Written by Freddie Dawson | 16th December 2021
What do Luxembourg and Malta’s legal cannabis plans mean in practice?
Written by Freddie Dawson | 9th December 2021
New German coalition plans to legalise cannabis – but when will sales begin?
Written by Freddie Dawson | 25th November 2021
Why are specialist vape retailers around the world turning away from CBD online?
Written by Freddie Dawson | 17th November 2021
eBay prepares to take on Amazon with the launch of UK trial of CBD sales
Written by Freddie Dawson | 10th November 2021
The suspense continues, still with no end in sight to the UK’s novel food saga
Written by Freddie Dawson | 3rd November 2021
US states fall over themselves backwards to sow further confusion over delta-8
Written by Anthony Traurig | 21st October 2021
Charlotte’s Web new dietary ingredient application did include ValidCare data
Written by Freddie Dawson | 14th October 2021
Could CBD companies face scrutiny from another US regulatory agency?
Written by Freddie Dawson | 6th October 2021
What does the recent USPTO trademark decision mean for the industry?
Written by Freddie Dawson | 22nd September 2021
FDA and CDC warnings won’t signal the end of the delta-8 THC market in the US
Written by Freddie Dawson | 16th September 2021
Beverage brands still searching for the right solution to their drink problem
Written by CannIntelligence | 9th September 2021
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
Written by CannIntelligence | 1st September 2021
What conclusions can be drawn from the FDA rejection of full hemp extracts as supplements?
Written by CBD-Intel | 18th August 2021
What lies behind the CBD industry’s continued interest in the field of nicotine replacement?
Written by CBD-Intel | 11th August 2021
Could e-cig ‘shake and vape’ be a model for sales of ingestible CBD products?
Written by CBD-Intel | 5th August 2021
What can be concluded from the appointment of Lina Khan as new chair of the Federal Trade Commission (FTC)?
Written by CBD-Intel | 22nd July 2021
EU novel food assessment: No easy end in sight
Written by CBD-Intel | 16th July 2021
Why the UK government might not follow task force advice on homegrown hemp
Written by CannIntelligence | 8th July 2021
UK taskforce urges reform – but will it happen, and will it boost the market?
Written by Freddie Dawson | 28th June 2021
Why is crowd-funding an increasingly popular option for CBD companies to raise investment?
Written by JuditBach | 21st June 2021
What changes can be expected in the near future for the regulation of CBD in France?
Written by JuditBach | 11th June 2021
New UK cannabis industry body brings together a wide range of expertise
Written by CannIntelligence | 3rd June 2021
Is delta-8 THC a legal product in the US?
Written by CannIntelligence | 20th May 2021
What can we learn from the distribution of brands by main product category and retailer type in the UK?
Written by CannIntelligence | 14th May 2021
Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?
Written by CannIntelligence | 7th May 2021
What is the state of science behind minor cannabinoids really like?
Written by CannIntelligence | 29th April 2021
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
Written by CannIntelligence | 22nd April 2021
Is delta-8 THC really the next big thing?
Written by CannIntelligence | 14th April 2021
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
Written by CannIntelligence | 8th April 2021
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
Written by CannIntelligence | 1st April 2021
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.